1. Home
  2. IXHL vs NA Comparison

IXHL vs NA Comparison

Compare IXHL & NA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Incannex Healthcare Inc.

IXHL

Incannex Healthcare Inc.

HOLD

Current Price

$3.52

Market Cap

37.0M

Sector

N/A

ML Signal

HOLD

NA

Nano Labs Ltd

HOLD

Current Price

$1.93

Market Cap

43.4M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
IXHL
NA
Founded
2001
2019
Country
Australia
China
Employees
N/A
N/A
Industry
Semiconductors
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
37.0M
43.4M
IPO Year
2024
2021

Fundamental Metrics

Financial Performance
Metric
IXHL
NA
Price
$3.52
$1.93
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
80.0K
13.5K
Earning Date
05-15-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$12,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.16
$1.58
52 Week High
$6.39
$6.30

Technical Indicators

Market Signals
Indicator
IXHL
NA
Relative Strength Index (RSI) 64.69 52.31
Support Level $2.79 $1.64
Resistance Level $3.68 $1.96
Average True Range (ATR) 0.14 0.09
MACD 0.06 0.01
Stochastic Oscillator 100.00 81.25

Price Performance

Historical Comparison
IXHL
NA

About IXHL Incannex Healthcare Inc.

Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.

About NA Nano Labs Ltd

Nano Labs Ltd is a Web 3.0 infrastructure and product solution provider, as well as a crypto treasury company. It is focused on the development of HTC chips and HPC chips. In addition, the company has established BNB value investment and adopted BNB (a crypto token) as the primary reserve asset. Furthermore, it has launched the iPollo Claw, a dedicated hardware solution for the OpenClaw AI Agent Ecosystem. Nano Labs derives revenue mainly from its HTC and HPC offerings, which comprise Darkbird series HPC chips that feature high performance and high energy consumption efficiency, and Cuckoo series chips, used in GPUs. Geographically, the company generates maximum revenue from the People's Republic of China (PRC), and the rest from Singapore, Hong Kong, the United States, and other markets.

Share on Social Networks: